[1] ZIMMET P Z,COLLINS V R,DOWSE G K,et al.Is hyperinsulinaemia a central characteristic of a chronic cardiovascular risk factor clustering syndrome?Mixed findings in Asian Indian,Creole and Chinese Mauritians[J].Diabetic Medicine,1994,11(4):388-396.
[2] SÖDERBERG S,ZIMMET P,TUOMILEHTO J,et al.High incidence of type 2 diabetes and increasing conversion rates from impaired fasting glucose and impaired glucose tolerance to diabetes in Mauritius[J].Journal of Internal Medicine,2004,256(1):37-47.
[3] ZIMMET P,ALBERTI K G,SHAW J.Global and societal implications of the diabetes epidemic[J].Nature,2001,414(6865):782-787.
[4] VINIK A I.Diabetic neuropathy: pathogenesis and therapy[J].The American Journal of Medicine,1999,107(2B):17S-26S.
[5] JAKUS V.The role of free radicals, oxidative stress and antioxidant systems in diabetic vascular disease[J].Bratisl Lek Listy,2000,101(10):541-551.
[6] MUSSA F F,PEDEN E K,ZHOU W,et al. Iliac vein stenting for chronic venous insufficiency[J].Texas Heart Institute Journal,2007,34(1):60-66.
[7] RUGGIERO N J,JAFF M R.The current management of aortic,common iliac,and external iliac artery disease:basic data underlying clinical decision making[J].Ann Vasc Surg,2011,25(7):990-1003.
[8] BERLAUK J F,ABRAMS J H,GILMOUR I J,et al.Preoperative optimization of cardiovascular hemodynamics improves outcome in peripheral vascular surgery.A prospective,randomized clinical trial[J].Ann Surg,1991,214(3):289-297.
[9] CHARAKIDA M,MASI S,LUSCHER T F,et al.Assessment of atherosclerosis: the role of flow-mediated dilatation[J].Eur Heart J,2010,31(23):2854-2861.
[10] BENHAMOU Y,EDET S,BEGARIN L,et al.Transcutaneous oxymetry as predictive test of peripheral vascular revascularization in haemodialysis population[J].Nephrol Dial Transplant,2012,27(5):2066-2069.
[11] FLYNN J T,BANCALARI E,SNYDER E S,et al.A cohort study of transcutaneous oxygen tension and the incidence and severity of retinopathy of prematurity[J].N Eng J Med,1992,326(16):1050-1054.
[12] KUSWARDHANI R A,SUASTIKA K.Age and homocystein were risk factor for peripheral arterial disease in elderly with type 2 diabetes mellitus[J].Acta Med Indones,2010,42(2):94-99.
[13] CHANTELAU E,MA X Y,HERMBERGER S,et al.Effect of medial arterial calcification on O2 supply to exercising diabetic feet[J].Diabetes,1990,39(8):938-941.
[14] NAVANEETHAN S D,ALOUDAT S,SINGH S.A systematic review of patient and health system characteristics associated with late referral in chronic kidney disease[J].BMC Nephrol,2008,9(3):1471-2369.
[15] WANG C H,LAN Y J,YEH C H,et al.Timing of gangrene tissue debridement after autologous bone marrow cell implantation in patients with superficial femoral arterial occlusion: preliminary experiences[J].J Cardiovasc Surg(Torino),2012,53(4):507-516.
[16] DEPAIRON M,KRAHENBUHL B,VAUCHER J,et al.Determination of the amputation level by transcutaneous PO2 measurement and distal arterial systolic pressure[J].J Mal Vasc,1986,11(3):229-234.
[17] RODRIGUES L M,PINTO P C,LEAL A.Transcutaneous flow related variables measured in vivo:the effects of gender[J].BMC Dermatol,2001,1:4.
[18] LIU Y,STEINACKER J M,STAUCH M.Transcutaneous oxygen tension and Doppler ankle pressure during upper and lower body exercise in patients with peripheral arterial occlusive disease[J].Angiology,1995,46(8):689-698.
[19] KARVONEN J,VUORIMAA T.Heart rate and exercise intensity during sports activities.Practical application[J].Sports Med,1998,5(5):303-311.
[20] TREMPER K K,WAXMAN K,SHOEMAKER W C.Effects of hypoxia and shock on transcutaneous PO2 values in dogs[J].Crit Care Med,1979,7(12):526-531.
[21] SHOEMAKER W C.Transcutaneous PO2 sensors and their application to clinical monitoring and diagnosis[J].Acute Care,1983-1984,10(2):103-111. |